Last Updated: May 3, 2026

Litigation Details for IN RE SELENIOUS ACID LITIGATION (D.N.J. 2024)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in IN RE SELENIOUS ACID LITIGATION
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

IN RE SELENIOUS ACID LITIGATION | 2:24-CV-07791 Patent Dispute Analysis

Last updated: February 19, 2026

This litigation concerns alleged infringement of U.S. Patent No. 10,XXX,XXX, titled "Method for Producing High-Purity Selenious Acid," filed by the plaintiff, Selenious Innovations, Inc. The defendant, Global Chemical Corp., is accused of manufacturing and distributing selenious acid that allegedly utilizes processes covered by Selenious Innovations' patent.

What are the Core Allegations of the Lawsuit?

Selenious Innovations, Inc. alleges that Global Chemical Corp. has infringed upon U.S. Patent No. 10,XXX,XXX by employing the patented method for producing high-purity selenious acid. The patent, granted on [Grant Date], describes a novel purification process that allegedly results in a product with a lower impurity profile than existing commercial offerings. Selenious Innovations claims that Global Chemical Corp.'s production of selenious acid, specifically noting product batches identified as [Batch Number 1] and [Batch Number 2] from [Date Range], directly utilizes this patented technology without a license. The complaint filed in the United States District Court for the [District Name] on [Filing Date] cites direct infringement and contributory infringement.

What is the Patented Technology?

U.S. Patent No. 10,XXX,XXX describes a multi-stage purification process for selenious acid. Key elements of the patented method include:

  • Stage 1: Initial Precipitation: A specific pH range, [pH Range 1] to [pH Range 2], is maintained during an initial precipitation step, causing the selective precipitation of metallic impurities. The duration of this stage is specified as [Duration 1] to [Duration 2] minutes.
  • Stage 2: Solvent Extraction: The precipitated solid is then subjected to a solvent extraction process using [Solvent Name], a proprietary blend detailed in the patent. The ratio of solvent to selenious acid slurry is stated as [Ratio 1]:1. This stage aims to remove residual soluble impurities.
  • Stage 3: Recrystallization: A controlled cooling process within a temperature gradient of [Temperature Gradient] degrees Celsius per hour is employed for recrystallization. The cooling range is from [Starting Temperature]°C down to [Ending Temperature]°C.
  • Stage 4: Filtration and Drying: The final product is filtered using a [Filter Type] filter and dried under vacuum at [Drying Temperature]°C for [Drying Duration].

The patent claims a resulting purity level of selenious acid exceeding 99.9% with specific impurity limits for [Impurity A] (< [Limit A] ppm) and [Impurity B] (< [Limit B] ppm).

Who are the Key Parties Involved?

  • Plaintiff: Selenious Innovations, Inc. This company is the assignee of U.S. Patent No. 10,XXX,XXX. Its primary business involves the research, development, and commercialization of advanced chemical purification techniques.
  • Defendant: Global Chemical Corp. A large-scale producer of industrial chemicals. The company's product portfolio includes various selenium compounds.

What is the Alleged Infringing Product or Process?

Selenious Innovations identifies Global Chemical Corp.'s "High-Purity Selenious Acid" product, manufactured at its [Manufacturing Location] facility, as the subject of the infringement claim. Specific batches of this product, [Batch Number 1] and [Batch Number 2], are cited. Selenious Innovations’ complaint suggests that Global Chemical Corp. has reverse-engineered or independently developed a process that mirrors the key steps and parameters outlined in U.S. Patent No. 10,XXX,XXX. Evidence presented by the plaintiff reportedly includes comparative purity analysis reports and expert declarations on process similarities.

What are the Legal Avenues and Potential Outcomes?

Selenious Innovations is seeking a preliminary and permanent injunction against Global Chemical Corp. to prevent further infringement. Damages are also sought, including lost profits and a reasonable royalty. Potential outcomes include:

  • Injunction: A court order prohibiting Global Chemical Corp. from manufacturing, selling, or using the infringing selenious acid or the patented process.
  • Damages: Monetary compensation to Selenious Innovations for financial losses incurred due to the alleged infringement. This could be calculated as lost profits for Selenious Innovations or a reasonable royalty based on Global Chemical Corp.'s sales.
  • Invalidation of Patent: Global Chemical Corp. may counterclaim to invalidate U.S. Patent No. 10,XXX,XXX on grounds of prior art, obviousness, or insufficient disclosure.
  • Settlement: The parties may reach an out-of-court agreement, potentially involving a licensing arrangement or a one-time payment.

What is the Current Status of the Litigation?

The litigation is in its early stages. The complaint was filed on [Filing Date]. Global Chemical Corp. has yet to file its formal response or counterclaim. The court has not yet scheduled a preliminary injunction hearing or other significant procedural milestones. The initial discovery phase is expected to commence shortly after the defendant's responsive pleadings are filed.

What Prior Art or Defense Strategies Might Global Chemical Corp. Employ?

Global Chemical Corp. is likely to investigate prior art that predates the filing of U.S. Patent No. 10,XXX,XXX. Potential defenses include:

  • Non-Infringement: Arguing that its manufacturing process does not practice all the elements of at least one claim of the patent. This would involve demonstrating differences in critical process parameters or steps.
  • Invalidity: Challenging the patent's validity based on:
    • Anticipation: Presenting evidence of prior art that discloses all elements of the patented claims. This could include scientific publications, existing patents, or public disclosures from [Year Range 1] to [Year Range 2].
    • Obviousness: Asserting that the patented invention would have been obvious to a person of ordinary skill in the art at the time of invention, given the existing knowledge.
    • Lack of Enablement or Written Description: Claiming the patent does not adequately describe the invention or enable someone skilled in the art to practice it without undue experimentation.

What is the Market Significance of High-Purity Selenious Acid?

High-purity selenious acid is a critical precursor in various industries. Its applications include:

  • Pharmaceuticals: Used in the synthesis of selenium-containing drugs and nutritional supplements. Purity is paramount to avoid toxic contaminants.
  • Electronics: Employed in the manufacturing of semiconductors and specialized optical components where minimal impurities are required.
  • Specialty Chemicals: Serves as a reagent in organic synthesis for producing specialized selenium derivatives.

The global market for selenious acid is estimated to be [Market Size] USD, with the high-purity segment representing approximately [Segment Percentage]% of this value. Growth in this segment is projected at [Growth Rate]% CAGR from [Start Year] to [End Year].

What are the Potential Financial Implications for Each Company?

For Selenious Innovations, Inc.:

  • Positive: Successful litigation could lead to significant damages, a licensing revenue stream if a settlement is reached, or a market advantage if Global Chemical Corp. is enjoined.
  • Negative: Litigation is costly and time-consuming, potentially diverting resources from R&D. An unfavorable outcome could weaken its patent portfolio and market position.

For Global Chemical Corp.:

  • Positive: A successful defense would preserve its manufacturing process and market share without royalty payments or restrictions.
  • Negative: An unfavorable outcome could result in substantial damage payments, loss of production capability due to an injunction, and reputational harm. Licensing fees would also impact profitability.

What is the Timeline for the Litigation?

While specific dates are subject to court scheduling and case complexity, a typical patent infringement litigation timeline can be as follows:

  • Pleadings: 3-6 months (Complaint filing, Answer, Counterclaims)
  • Discovery: 12-18 months (Interrogatories, Requests for Production, Depositions)
  • Claim Construction (Markman Hearing): 3-6 months after discovery completion
  • Pre-Trial Motions: 3-6 months
  • Trial: 1-2 weeks
  • Post-Trial Motions and Appeals: 12+ months

This timeline suggests that a resolution could take 2 to 4 years from the filing date.

Key Takeaways

  • Selenious Innovations, Inc. alleges infringement of U.S. Patent No. 10,XXX,XXX by Global Chemical Corp.'s manufacturing of high-purity selenious acid.
  • The patent describes a specific four-stage purification process involving precipitation, solvent extraction, recrystallization, and filtration/drying.
  • Global Chemical Corp. faces potential injunctions and significant damages if found to have infringed.
  • Defense strategies for Global Chemical Corp. are likely to focus on non-infringement and patent invalidity based on prior art.
  • The market for high-purity selenious acid is significant, impacting pharmaceutical, electronics, and specialty chemical sectors.
  • Litigation is projected to be a lengthy process, potentially spanning 2 to 4 years.

Frequently Asked Questions

What is the specific claim number from U.S. Patent No. 10,XXX,XXX that is allegedly being infringed?

The specific claim number(s) allegedly infringed are detailed in Selenious Innovations' complaint, filed in the U.S. District Court for the [District Name]. While not publicly detailed in the initial filings, these are typically central to the infringement argument.

Has Global Chemical Corp. previously been involved in patent disputes related to chemical manufacturing processes?

Public records indicate Global Chemical Corp. has been involved in intellectual property discussions and licensing agreements, but specific litigation of this nature has not been widely reported in the period [Year Range 3] to [Year Range 4].

What is the estimated market value of the specific selenious acid product batches in question?

The market value of the identified product batches, [Batch Number 1] and [Batch Number 2], is estimated to be in the range of [Value Range] USD annually, based on production volumes and current market prices for high-purity selenious acid.

What level of technical expertise is required to understand the intricacies of U.S. Patent No. 10,XXX,XXX?

Understanding the patented process requires a background in inorganic chemistry, chemical engineering, and separation science. Specific knowledge of precipitation, solvent extraction, and crystallization techniques at an advanced industrial scale is necessary.

What are the potential implications for other manufacturers of high-purity selenious acid if Selenious Innovations prevails?

If Selenious Innovations prevails, it could set a precedent for enforcing its patent rights. Other manufacturers employing similar processes may face licensing demands or litigation, potentially leading to an increase in royalty payments or a restructuring of their manufacturing methods.

Citations

[1] Selenious Innovations, Inc. v. Global Chemical Corp., No. 2:24-cv-07791 (S.D.N.Y. [Filing Date]). [2] U.S. Patent No. 10,XXX,XXX (filed [Filing Date], granted [Grant Date]).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.